MKI67 and breast cancer: Triiodothyronine (T3) is shown to influence the EVTs invasion into the decidua, and in breast cancer-positive HER2, free triiodothyronine (FT3) (even in normal concentration) is shown to be negatively correlated with cell proliferation (ki67) [47,48].